GlassScriptPhysician profile
Cheryl A Canto
NPI 1164423216
$4,820.68
in general payments reported to CMS, 2019-2025
38 companies · $649 in 2025
The $649 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,059 · 2020: $1,088 · 2021: $257 · 2022: $105 · 2023: $616 · 2024: $1,046 · 2025: $649.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,310.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $959.12 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $461.23 | 2019-2025 | Repatha, Otezla, Otezla |
| Astrazeneca Pharmaceuticals LP | $448.91 | 2019-2025 | Airsupra, Breztri |
| Allergan, INC. | $273.25 | 2019-2020 | |
| Pfizer INC. | $223.32 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $221.32 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $205.23 | 2019-2020 | |
| Lilly USA, LLC | $173.02 | 2020-2025 | Mounjaro |
| Dexcom, INC. | $138.54 | 2023-2024 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $136.68 | 2019-2025 | Veozah |
| Sanofi-Aventis U.S. LLC | $133.95 | 2019-2023 | |
| Silk Road Medical, INC. | $125.00 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Amarin Pharma, INC. | $118.29 | 2019-2020 | |
| Glaxosmithkline, LLC. | $106.60 | 2019-2025 | Trelegy Ellipta, Shingrix |
| Merck Sharp & Dohme LLC | $98.20 | 2019-2024 | Dificid |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Canto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.